JAK Inhibitor Tapering in Rheumatoid Arthritis: Implications for Patients in Sustained Remission - Rheumatology Advisor

JAK Inhibitor Tapering in Rheumatoid Arthritis: Implications for Patients in Sustained Remission  Rheumatology Advisor

Data have demonstrated that patients with rheumatoid arthritis in long-term remission can safely taper their biologic therapy.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases